Y.-S. Lin et al. / Tetrahedron xxx (2017) 1e8
7
6.65 (d, J ¼ 1.6 Hz, 1H), 4.09 (t, J ¼ 7.6 Hz, 1H), 3.84 (s, 3H), 3.78 (s,
3H), 3.77 (s, 3H), 3.75 (s, 3H), 3.24 (d, J ¼ 7.6 Hz, 2H); 13C NMR
4.5.20. Compound (1t)
Yield ¼ 76% (299 mg); Colorless oil; HRMS (ESI, Mþþ1) calcd for
28H27O2 395.2011, found 395.2014; 1H NMR (400 MHz, CDCl3):
7.69e7.66 (m, 2H), 7.62 (d, J ¼ 8.0 Hz, 2H), 7.53e7.49 (m, 2H),
(100 MHz, CDCl3):
d
157.79, 157.66, 148.53, 147.18, 137.51, 136.87,
C
d
132.46, 129.94 (2x), 128.78 (2x), 119.66, 113.61 (2x), 113.39 (2x),
111.56, 110.91, 55.75, 55.71, 55.12, 55.09, 51.94, 41.58; Anal. Calcd for
7.44e7.39 (m, 3H), 7.32e7.22 (m, 3H), 7.17e7.15 (m, 2H), 6.90 (dd,
J ¼ 1.6, 8.0 Hz, 1H), 6.87 (d, J ¼ 8.0 Hz, 1H), 6.79 (d, J ¼ 1.6 Hz, 1H),
4.34 (t, J ¼ 7.6 Hz, 1H), 3.92 (s, 3H), 3.87 (s, 3H), 3.53e3.43 (m, 2H);
C
24H26O4: C, 76.17; H, 6.92. Found: C, 76.31; H, 7.14.
13C NMR (100 MHz, CDCl3):
d 148.55, 147.31, 143.75, 140.72, 140.16,
4.5.15. Compound (1o)
138.86, 136.79, 129.02 (2x), 128.60 (2x), 128.19 (2x), 127.99 (2x),
126.97, 126.92 (2x), 126.82 (2x), 125.81, 119.75, 111.64, 110.97, 55.66
(2x), 52.18, 42.22.
Yield ¼ 60% (220 mg); Colorless oil; HRMS (ESI, Mþþ1) calcd for
C
23H24FO3 337.1710, found 337.1713; 1H NMR (400 MHz, CDCl3):
d
7.10 (d, J ¼ 8.8 Hz, 2H), 6.95e6.91 (m, 2H), 6.89e6.79 (m, 4H), 6.76
(d, J ¼ 8.4 Hz, 1H), 6.72 (dd, J ¼ 2.0, 8.0 Hz, 1H), 6.62 (d, J ¼ 2.0 Hz,
1H), 4.06 (t, J ¼ 8.0 Hz, 1H), 3.84 (s, 3H), 3.78 (s, 3H), 3.77 (s, 3H),
4.5.21. Compound (1u)
Yield ¼ 72% (305 mg); Colorless gum; HRMS (ESI, Mþþ1) calcd
3.26 (d, J ¼ 8.0 Hz, 2H); 13C NMR (100 MHz, CDCl3):
d 161.20 (d,
for C29H29O3 425.2117, found 425.2122; 1H NMR (400 MHz, CDCl3):
J ¼ 241.9 Hz), 157.89, 148.60, 147.29, 137.14, 136.50, 136.02 (d,
J ¼ 3.0 Hz), 130.40 (d, J ¼ 7.5 Hz, 2x), 128.75 (2x), 119.60, 114.74 (d,
J ¼ 21.2 Hz, 2x), 113.67 (2x), 111.45, 110.91, 55.78, 55.73, 55.15, 51.92,
41.65.
d
7.57e7.55 (m, 2H), 7.48 (d, J ¼ 8.4 Hz, 2H), 7.43e7.39 (m, 2H),
7.33e7.26 (m, 3H), 7.20e7.11 (m, 4H), 7.07e7.04 (m, 2H), 6.66 (d,
J ¼ 8.4 Hz, 1H), 4.65 (t, J ¼ 8.0 Hz, 1H), 3.84 (s, 3H), 3.81 (s, 3H), 3.47
(s, 3H), 3.33 (d, J ¼ 8.0 Hz, 2H); 13C NMR (100 MHz, CDCl3):
d 152.08,
151.65, 144.11, 142.25, 140.94, 140.53, 138.65, 130.55, 129.11 (2x),
128.66 (2x), 128.43 (2x), 128.03 (2x), 126.98, 126.91 (2x), 126.82
(2x), 122.23, 125.83, 107.02, 60.58, 60.51, 55.87, 45.09, 41.71.
4.5.16. Compound (1p)
Yield ¼ 73% (276 mg); Colorless oil; HRMS (ESI, Mþþ1) calcd for
C
24H27O4 379.1909, found 379.1912; 1H NMR (400 MHz, CDCl3):
d
7.19e7.09 (m, 5H), 7.04e6.98 (m, 3H), 6.77 (d, J ¼ 8.8 Hz, 2H), 6.64
4.6. Compound (1v, CDP-840)
(d, J ¼ 8.8 Hz, 1H), 4.54 (t, J ¼ 8.0 Hz, 1H), 3.83 (s, 3H), 3.81 (s, 3H),
3.75 (s, 3H), 3.46 (s, 3H), 3.25 (dd, J ¼ 3.2, 8.0 Hz, 2H); 13C NMR
K2CO3 (400 mg, 2.9 mmol) was added to a solution of 5o and 5p
(1.0 mmol) in acetone (10 mL) at rt. The reaction mixture was
stirred at rt for 10 min. Cyclopenty bromide (450 mg, 3.0 mmol)
was added to the reaction mixture at rt. The reaction mixture was
stirred at reflux for 8 h. The reaction mixture was cooled to rt and
the solvent was concentrated. The residue was diluted with water
(10 mL) and the mixture was extracted with CH2Cl2 (3 ꢁ 20 mL).
The combined organic layers were washed with brine, dried,
filtered and evaporated to afford crude product under reduced
pressure. Purification on silica gel (hexanes/EtOAc ¼ 4/1e2/1)
afforded skeleton 5q and 5r. For 5q, Yield ¼ 46% (207 mg); Colorless
solid; mp ¼ 147e149 ꢀC (recrystallized from hexanes and EtOAc);
HRMS (ESI, Mþþ1) calcd for C27H31O4S 451.1943, found 451.1944;
(100 MHz, CDCl3):
d 157.64, 151.93, 151.55, 142.20, 140.67, 137.01,
131.04, 129.09 (2x), 128.95 (2x), 127.96 (2x), 125.74, 122.04, 113.45
(2x), 106.94, 60.56, 60.48, 55.86, 55.14, 44.59, 41.92.
4.5.17. Compound (1q)
Yield ¼ 68% (277 mg); Colorless oil; HRMS (ESI, Mþþ1) calcd for
C
d
25H29O5 409.2015, found 409.2018; 1H NMR (400 MHz, CDCl3):
7.12 (d, J ¼ 8.8 Hz, 2H), 7.01 (d, J ¼ 8.4 Hz, 1H), 6.95 (d, J ¼ 8.4 Hz,
2H), 6.79 (d, J ¼ 8.8 Hz, 2H), 6.73 (d, J ¼ 8.4 Hz, 2H), 6.65 (d,
J ¼ 8.8 Hz, 1H), 4.51 (t, J ¼ 7.6 Hz, 1H), 3.84 (s, 3H), 3.83 (s, 3H), 3.76
(s, 3H), 3.74 (s, 3H), 3.50 (s, 3H), 3.26e3.16 (m, 2H); 13C NMR
(100 MHz, CDCl3):
d 157.63, 157.60, 151.88, 151.54, 142.19, 137.05,
1H NMR (400 MHz, CDCl3):
d
7.51 (d, J ¼ 8.0 Hz, 2H), 7.21e7.10 (m,
132.72, 131.11, 129.93 (2x), 128.94 (2x), 121.99, 113.42 (2x), 113.34
(2x), 106.94, 60.51, 60.48, 55.81, 55.09, 55.07, 44.76, 40.99; Anal.
Calcd for C25H28O5: C, 73.51; H, 6.91. Found: C, 73.72; H, 6.80.
7H), 6.65 (d, J ¼ 8.8 Hz, 1H), 6.61 (d, J ¼ 2.0 Hz, 1H), 6.60 (dd, J ¼ 2.0,
8.8 Hz, 1H), 4.63e4.61 (m, 1H), 4.53 (t, J ¼ 7.2 Hz, 1H), 3.85 (d,
J ¼ 7.2 Hz, 2H), 3.76 (s, 3H), 2.36 (s, 3H), 1.88e1.78 (m, 4H),
1.63e1.56 (m, 4H) 13C NMR (100 MHz, CDCl3):
d 148.91, 147.63,
4.5.18. Compound (1r)
144.10, 141.74, 136.67, 133.82, 129.40 (2x), 128.63 (2x), 127.97 (2x),
127.47 (2x), 126.73, 119.51, 114.71, 111.96, 80.30, 61.89, 56.03, 45.71,
32.74, 32.72, 24.02, 24.00, 21.50. Single-crystal X-Ray diagram:
crystal of compound 5q was grown by slow diffusion of EtOAc into a
solution of compound 5q in CH2Cl2 to yield colorless prisms. The
compound crystallizes in the monoclinic crystal system, space
group P 21/c, a ¼ 9.2777(10) Å, b ¼ 12.0117(13) Å, c ¼ 21.164(2) Å,
Yield ¼ 60% (238 mg); Colorless oil; HRMS (ESI, Mþþ1) calcd for
C
d
24H26FO4 397.1815, found 397.1820; 1H NMR (400 MHz, CDCl3):
7.08 (d, J ¼ 8.8 Hz, 2H), 6.98 (d, J ¼ 8.4 Hz, 1H), 6.96e6.94 (m, 2H),
6.88e6.82 (m, 2H), 6.79e6.75 (m, 2H), 6.64 (d, J ¼ 8.8 Hz, 1H), 4.46
(t, J ¼ 7.6 Hz, 1H), 3.83 (s, 3H), 3.81 (s, 3H), 3.76 (s, 3H), 3.48 (s, 3H),
3.27e3.17 (m, 2H); 13C NMR (100 MHz, CDCl3):
d 161.18 (d,
J ¼ 241.8 Hz), 157.70, 152.02, 151.54, 142.23, 136.67, 136.24 (d,
J ¼ 2.3 Hz), 130.77, 130.40 (d, J ¼ 7.5 Hz, 2x), 128.94 (2x), 121.93,
114.69 (d, J ¼ 21.2 Hz, 2x), 113.49 (2x), 106.94, 60.56, 60.51, 55.85,
55.14, 44.84, 41.05.
V ¼ 2311.6(4) Å3, Z ¼ 4, dcalcd ¼ 1.295 mg/cm3, F(000) ¼ 960, 2
q
range 1.959e26.457ꢀ,
R
indices (all data) R1
¼
0.1260,
wR2 ¼ 0.2145. For 5r, Yield ¼ 34% (153 mg); Colorless gum; HRMS
(ESI, Mþþ1) calcd for C27H31O4S 451.1943, found 451.1944; 1H NMR
(400 MHz, CDCl3):
d
7.50 (d, J ¼ 8.4 Hz, 2H), 7.21e7.10 (m, 7H),
4.5.19. Compound (1s)
6.65e6.56 (m, 3H), 4.67e4.63 (m, 1H), 4.54 (t, J ¼ 7.2 Hz, 1H), 3.86
(d, J ¼ 7.2 Hz, 2H), 3.72 (s, 3H), 2.36 (s, 3H), 1.89e1.78 (m, 4H),
Yield ¼ 78% (284 mg); Colorless oil; HRMS (ESI, Mþþ1) calcd for
C
27H25O 365.1905, found 365.1911; 1H NMR (400 MHz, CDCl3):
1.63e1.56 (m, 4H); 13C NMR (100 MHz, CDCl3):
d 149.80, 146.68,
d
7.58e7.55 (m, 2H), 7.49 (d, J ¼ 8.4 Hz, 2H), 7.44e7.40 (m, 2H),
144.08, 141.71, 136.67, 133.53, 129.37 (2x), 128.62 (2x), 127.96 (2x),
127.50 (2x), 126.74, 119.63, 114.51, 111.86, 80.22, 61.89, 55.98, 45.81,
32.79 (2x), 24.02 (2x), 21.49. t-BuOK (67 mg, 0.6 mmol) was added
to a stirred solution of 5q (180 mg, 0.4 mmol) in DMF (5 mL) at rt.
The reaction mixture was stirred at 80 ꢀC for 4 h 6d (200 mg,
1.0 mmol) in DMF (1 mL) was added to the reaction mixture at rt.
After 10 min, Pd(OAc)2 (11 mg, 0.05 mmol) in DMF (1 mL) was
7.34e7.27 (m, 3H), 7.21e7.12 (m, 5H), 7.05e7.03 (m, 2H), 6.82 (d,
J ¼ 8.8 Hz, 2H), 4.24 (d, J ¼ 7.6 Hz, 1H), 3.77 (s, 3H), 3.37 (d,
J ¼ 7.6 Hz, 2H); 13C NMR (100 MHz, CDCl3):
d 157.92, 144.02, 140.89,
140.30, 138.89, 136.48, 129.09 (2x), 128.96 (2x), 128.68 (2x), 128.28
(2x), 128.06 (2x), 127.02 (3x), 126.94 (2x), 125.86, 113.73 (2x), 55.18,
51.89, 42.26.
Please cite this article in press as: Lin Y-S, et al., Palladium-mediated synthesis of 1,1,2-triarylethanes. Application to the synthesis of CDP-840,